Journal of Reproduction & Infertility

Journal of Reproduction & Infertility

The Synergistic Effect of Autophagy and Apoptosis in Iraqi Women with Polycystic Ovary Syndrome

Authors
Mustafa Riyadh Abdullah 1
Hazima Mossa Alabassi 2
1 Department of Pharmacology and Toxicology, College of Pharmacy, Mustansiriyah University, Baghdad, Iraq
2 Department of Biology, College of Education for Pure Science (Ibn Al-Haitham), University of Baghdad, Baghdad, Iraq, Baghdad, Iraq
10.18502/jri.v26i1.18780
Abstract
Background: Apoptosis and autophagy play important roles in the development and maturation of the ovaries in women. Any abnormalities in these processes may lead to conditions such as polycystic ovary syndrome (PCOS); therefore, evaluating the synergistic effects of apoptosis and autophagy in PCOS patients may explain the complexity of this disease. Methods: This study included 68 patients diagnosed with PCOS and 66 non-PCOS women as control subjects, with ages ranging from 20 to 45 years. The serum levels and gene expression of Beclin-1 and programmed cell death 1 (PD-1) were assessed using ELISA and RT-PCR, respectively. Results: Serum Beclin-1 and PD-1 levels were considerably higher in women with PCOS compared to the control group (p<0.0001). Significant overexpression of Beclin-1 and PD-1 genes was observed in PCOS patients compared to the control group (p=0.019 and <0.0001). Higher Beclin-1 and PD-1 gene expression was observed in PCOS patients over 25 compared to controls over and under 25 (p<0.05) years of age. In obese PCOS patients (waist-hip ratio >0.8), gene expression of Beclin-1 and PD-1 was significantly higher than in controls (p<0.01). Beclin-1 gene overexpression was detected in PCOS patients with a family history of PCOS compared to those without such history (p<0.05). The statistical analysis demonstrated a positive association between hormonal profile, autophagy, and apoptosis in PCOS patients. Conclusion: These findings suggest that Beclin-1 and PD-1 may have a significant role in the development of PCOS. The study highlights the potential of targeting Beclin-1 and PD-1 as future directions for immunotherapeutic intervention in PCOS.
Keywords
Apoptosis
Autophagy
Beclin
1
oxidative stress
Pd
polycystic ovarian syndrome
  1. Glendining KA, Campbell RE. Recent advances in emerging PCOS therapies. Curr Opin Pharmacol. 2023;68:102345.
  2. Karkera S, Agard E, Sankova L. The clinical manifestations of polycystic ovary syndrome (PCOS) and the treatment options. Eur J Biol Med Sci Res. 2023;11(1):57-91.
  3. Abdullah MR, Alabassi HM. The potential influence of immune modulatory molecules (TGF-βIII and CTLA-4) in pathogenicity of PCOS. Karbala Int J Mod Sci. 2024;10(3):363-75.
  4. Cheng D, Zheng B, Sheng Y, Zeng Z, Mo Z. The roles of autophagy in the genesis and development of polycystic ovary syndrome. Reprod Sci. 2023;30(10):2920-31.
  5. Kumariya S, Ubba V, Jha RK, Gayen JR. Autophagy in ovary and polycystic ovary syndrome: role, dispute, and future perspective. Autophagy. 2021;17(10):2706-33.
  6. Kirat D, Alahwany AM, Arisha AH, Abdelkhalek A, Miyasho T. Role of macroautophagy in mammalian male reproductive physiology. Cells. 2023;12(9):1322.
  7. Harrath AH, Rahman MA, Bhajan SK, Bishwas AK, Rahman MDH, Alwasel S, et al. Autophagy and female fertility: mechanisms, clinical implications, and emerging therapies. Cells. 2024;13(16):1354.
  8. Sengupta P, Dutta S, Hassan MF. Polycystic ovary syndrome (PCOS) and oxidative stress. J Integr Sci Technol. 2024;12(3):752.
  9. Cao Z, Tian K, Ran Y, Zhou H, Zhou L, Ding Y, et al. Beclin-1: a therapeutic target at the intersection of autophagy, immunotherapy, and cancer treatment. Front Immunol. 2024;15:1506426.
  10. Prerna K, Dubey VK. Beclin1-mediated interplay between autophagy and apoptosis: new understanding. Int J Biol Macromol. 2022;204:258-73.
  11. Kopeina GS, Zhivotovsky B. Programmed cell death: past, present and future. Biochem Biophys Res Commun. 2022;633:55-8.
  12. Gutic B, Bozanovic T, Mandic A, Dugalic S, Todorovic J, Stanisavljevic D, et al. Programmed cell death-1 and its ligands: current knowledge and possibilities in immunotherapy. Clinics (Sao Paulo). 2023;78:100177.
  13. Liang C, Dao-Kuan Z, Guo-Qing T, Li L. Apoptotic mechanism of premature ovarian failure and rescue effect of traditional Chinese medicine: a review. J Tradit Chin Med. 2021;41(3):492-8.
  14. Wang J, Yin T, Liu S. Dysregulation of immune response in PCOS organ system. Front Immunol. 2023;14:1169232.
  15. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19-25.
  16. Yadav S, Tarware R. Waist hip ratio: an anatomical predictive marker of risk of PCOS. Int J Reprod Contracept Obstet Gynecol. 2019;8(4):1630-3.
  17. Morshed MS, Banu H, Akhtar N, Sultana T, Begum A, Zamilla M, et al. Luteinizing hormone to follicle-stimulating hormone ratio significantly correlates with androgen level and manifestations are more frequent with hyperandrogenemia in women with polycystic ovary syndrome. J Endocrinol Metab. 2021;11(1):14-21.
  18. Ghorbani P, Mollaei H, Arabzedeh S, Zahedi M. Upregulation of single nucleotide polymorphism of PD-1 gene (rs10204525) in chronic hepatitis B patients. Int Arch Med Microbiol. 2019;2(1):1-8.
  19. Lajevardi B, Bamdad T, Choobin H, Jamalidoust M, Namayandeh M. Impact of interplay between autophagy and interferon-alpha in HCV and HCV/HIV infection. Acta Virol. 2019;63(2):235-9.
  20. Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, et al. Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science. 1985;230(4732):1350-4.
  21. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402-8.
  22. Bushell A, Crespi BJ. The evolutionary basis of elevated testosterone in women with polycystic ovary syndrome: an overview of systematic reviews of the evidence. Front Reprod Health. 2024;6:1475132.
  23. Stener-Victorin E, Teede H, Norman RJ, Legro R, Goodarzi MO, Dokras A, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2024;10(1):27.
  24. Davoudi Z, Araghi F, Vahedi M, Mokhtari N, Gheisari M. Prolactin level in polycystic ovary syndrome (PCOS): an approach to the diagnosis and management. Acta Biomed. 2021;92(5):e2021291.
  25. Emanuel RHK, Roberts J, Docherty PD, Lunt H, Campbell RE, Möller K. A review of the hormones involved in the endocrine dysfunctions of polycystic ovary syndrome and their interactions. Front Endocrinol (Lausanne). 2022;13:1017468.
  26. Saei Ghare Naz M, Mousavi M, Mahboobifard F, Niknam A, Ramezani Tehrani F. A meta-analysis of observational studies on prolactin levels in women with polycystic ovary syndrome. Diagnostics (Basel). 2022;12(12):2924.
  27. Mahboobifard F, Rahmati M, Amiri M, Azizi F, Tehrani FR. To what extent does polycystic ovary syndrome influence the cut-off value of prolactin? findings of a community-based study. Adv Med Sci. 2022;67(1):79-86.
  28. Faron-Górecka A, Latocha K, Pabian P, Kolasa M, Sobczyk-Krupiarz I, Dziedzicka-Wasylewska M. The involvement of prolactin in stress-related disorders. Int J Environ Res Public Health. 2023;20 (4):3257.
  29. Xu XL, Huang ZY, Yu K, Li J, Fu XW, Deng SL. Estrogen biosynthesis and signal transduction in ovarian disease. Front Endocrinol (Lausanne). 2022;13:827032.
  30. Carmina E, Dreno B, Lucky WA, Agak WG, Dokras A, Kim JJ, et al. Female adult acne and androgen excess: a report from the multidisciplinary androgen excess and PCOS committee. J Endocr Soc. 2022;6(3):bvac003.
  31. Kim JJ, Yoon JW, Kim MJ, Kim SM, Hwang KR, Choi YM. Thyroid autoimmunity markers in women with polycystic ovary syndrome and controls. Hum Fertil (Camb). 2022;25(1):128-34.
  32. Fan H, Ren Q, Sheng Z, Deng G, Li L. The role of the thyroid in polycystic ovary syndrome. Front Endocrinol (Lausanne). 2023;14:1242050.
  33. van der Ham K, Stekelenburg KJ, Louwers YV, van Dorp W, Schreurs MWJ, van der Wal R, et al. The prevalence of thyroid dysfunction and hyperprolactinemia in women with PCOS. Front Endocrinol (Lausanne). 2023;14:1245106.
  34. Bucci I, Giuliani C, Di Dalmazi G, Formoso G, Napolitano G. Thyroid autoimmunity in female infertility and assisted reproductive technology outcome. Front Endocrinol (Lausanne). 2022;13:768363.
  35. Büyükyılmaz G, Koca SB, Adıgüzel KT, Boyraz M, Gurbuz F. The role of the AMH, SHBG, free androgen index and LH/FSH ratio in the diagnosis of polycystic ovary syndrome in adolescents. Turk J Pediatr Dis. 2024;18(1):34-40.
  36. Okigbo CC, Gill S, Hall JE. The hypothalamic-pituitary axis in polycystic ovary syndrome. In: Okigbo CC, Gill S, Hall JE, editors. Polycystic ovary syndrome: current and emerging concepts. Cham: Springer; 2022. p. 73-93.
  37. Taieb A, Feryel A. Deciphering the role of androgen in the dermatologic manifestations of polycystic ovary syndrome patients: a state-of-the-art review. Diagnostics (Basel). 2024;14(22):2578.
  38. Abdullah AAA, Kaem GG, Hasan LH. The role of Beclin 1 on autophagy in polycystic ovary syndrome. J Adv Zool. 2023;44:465-9.
  39. Soltani M, Moghimian M, Abtahi-Evari SH, Esmaeili SA, Mahdipour R, Shokoohi M. The effects of clove oil on the biochemical and histological parameters, and autophagy markers in polycystic ovary syndrome-model rats. Int J Fertil Steril. 2023;17(3):187-94.
  40. Liu S, Jia Y, Meng S, Luo Y, Yang Q, Pan Z. Mechanisms of and potential medications for oxidative stress in ovarian granulosa cells: a review. Int J Mol Sci. 2023;24(11):9205.
  41. Wu HH, Zhu Q, Liang N, Xiang Y, Xu TY, Huang ZC, et al. CISD2 regulates oxidative stress and mitophagy to maintain the balance of the follicular microenvironment in PCOS. Redox Rep. 2024;29(1):2377870.
  42. Chen X, Tang H, Liang Y, Wu P, Xie L, Ding Y, et al. Acupuncture regulates the autophagy of ovarian granulosa cells in polycystic ovarian syndrome ovulation disorder by inhibiting the PI3K/AKT/mTOR pathway through LncMEG3. Biomed Pharmacother. 2021;144:112288.
  43. Liu M, Zhu H, Zhu Y, Hu X. Guizhi fuling wan reduces autophagy of granulosa cells in rats with polycystic ovary syndrome via restoring the PI3K/AKT/mTOR signaling pathway. J Ethnopharmacol. 2021;270:113821.
  44. Hanna BS, Llao-Cid L, Iskar M, Roessner PM, Klett LC, Wong JKL, et al. Interleukin-10 receptor signaling promotes the maintenance of a PD-1int TCF-1+ CD8+ T cell population that sustains anti-tumor immunity. Immunity. 2021;54(12):2825-41.
  45. Han R, Gong X, Zhu Y, Liu X, Xia Y, Huang Y, et al. Relationship of PD‐1 (PDCD1) and PD‐L1 (CD274) single nucleotide polymorphisms with polycystic ovary syndrome. Biomed Res Int. 2021;2021:9596358.
  46. Al-Quraishy HA. Molecular basis of programmed cell death-1 gene an d its association with encoding protein levels of Iraqi women with polycystic ovarian syndrome. HIV Nurs. 2022;22(2):653-69.
  47. Li Y, Hong M, Huang X, Zhong L, Gu Y, Wang D, et al. PD-1 polymorphisms are associated with susceptibility of acute anterior uveitis in Chinese population. DNA Cell Biol. 2019;38(2):121-8.
  48. Fu J, Liu Y, Wang C, Zhang H, Yu B, Wang Y, et al. Persistent follicular granulosa cell senescence and apoptosis induced by methotrexate leading to oocyte dysfunction and aberrant embryo development. Clin Transl Sci. 2021;14(5):2043-54.
  49. Zhao N, Zhang C, Ding J, Wu H, Cheng W, Li M, et al. Altered T lymphocyte subtypes and cytokine profiles in follicular fluid associated with diminished ovary reserve. Am J Reprod Immunol. 2022;87(4):e13522.
  50. Abdullah M, Alabassi H. Unraveling immune regulatory mechanisms in PCOS: Role of T regulatory cells and receptors. NTU J Pure Sci. 2024;3(4):123-7.
  51. Chen X, He H, Long B, Wei B, Yang P, Huang X, et al. Acupuncture regulates the apoptosis of ovarian granulosa cells in polycystic ovarian syndrome-related abnormal follicular development through LncMEG3-mediated inhibition of miR-21-3p. Biol Res. 2023;56(1):31.
  52. Ali SE, Khaleel FM, Ali FE. A study of apelin-36 and GST levels with their relationship to lipid and other biochemical parameters in the prediction of heart diseases in PCOS women patients. Baghdad Sci J. 2020;17(3 Suppl):924.
  53. Gupta P, Agrawal S, Agarwal A, Pandey A, Kumar N, Ali W. Comparison of endocrine and metabolic profile of obese and lean PCOS women with infertility. Int J Infertil Fetal Med. 2022;13(3):125-8.
  54. Bednarczyk M, Dąbrowska-Szeja N, Łętowski D, Dzięgielewska-Gęsiak S, Waniczek D, Muc-Wierzgoń M. Relationship between dietary nutrient intake and autophagy-related genes in obese humans: a narrative review. Nutrients. 2024;16(23):4003.
  55. Wang L, O’Kane AM, Zhang Y, Ren J. Maternal obesity and offspring health: Adapting metabolic changes through autophagy and mitophagy. Obes Rev. 2023;24(7):e13567.
  56. He F, Liu Y, Yongmei Z. OX-LDL promotes insufficient autophagy and apoptosis of ovarian granulosa cells through regulation of ROS-mediated PI3K/Akt/mTOR pathway. J Clin Images Med Case Rep. 2023;4(3):2337.
  57. Ibrahim MII, Al-Saffar JM. Serum level evaluation of interleukin-18 in obese women with polycystic ovary syndrome. Iraqi J Sci. 2018;59(2):1989-94.
  58. Le CT, Khuat LT, Caryotakis SE, Wang M, Dunai C, Nguyen AV, et al. PD-1 blockade reverses obesity-mediated T cell priming impairment. Front Immunol. 2020;11:590568.
  59. Vick LV, Collins CP, Khuat LT, Wang Z, Dunai C, Aguilar EG, et al. Aging augments obesity-induced thymic involution and peripheral T cell exhaustion altering the "obesity paradox". Front Immunol. 2023;13:1012016.
  60. Kawai T, Autieri MV, Scalia R. Adipose tissue inflammation and metabolic dysfunction in obesity. Am J Physiol Cell Physiol. 2021;320(3):C375-91.
  61. Hildebrandt X, Ibrahim M, Peltzer N. Cell death and inflammation during obesity: “Know my methods, WAT (son).” Cell Death Differ. 2023;30(2):279-92.
  62. Boldis BV, Grünberger I, Cederström A, Björk J, Nilsson A, Helgertz J. Comorbidities in women with polycystic ovary syndrome: a sibling study. BMC Womens Health. 2024;24(1):221.
  63. Dumesic DA, Wood JR, Abbott DH, Strauss JF. A primate perspective on oocytes and transgenerational PCOS. Reprod Biomed Online. 2020;40(6):765-7.
  64. Monte APO, Bezerra MÉS, Menezes VG, Gouveia BB, Barberino RS, Lins T, et al. Involvement of phosphorylated Akt and FOXO3a in the effects of growth and differentiation factor-9 (GDF-9) on inhibition of follicular apoptosis and induction of granulosa cell proliferation after in vitro culture of sheep ovarian tissue. Reprod Sci. 2021;28(8):2174-85.
  65. Zhao Y, Zhao X, Jiang T, Xi H, Jiang Y, Feng X. A retrospective review on dysregulated autophagy in polycystic ovary syndrome: From pathogenesis to therapeutic strategies. Horm Metab Res. 2024;56(8):547-58.
  66. Yang R, Duan C, Zhang S, Guo Y, Shan X, Chen M, et al. High prolactin concentration induces ovarian granulosa cell oxidative stress, leading to apoptosis mediated by L-PRLR and S-PRLR. Int J Mol Sci. 2023;24(19):14407.
Journal of Reproduction & Infertility
Volume 26, Issue 1
Winter 2025
Pages 36-49